Greater Southern California Node
Principal Investigators:
Yih-Ing Hser, PhD [email]
Larissa Mooney, MD [email]
Integrated Substance Abuse Programs
University of California, Los Angeles
11075 Santa Monica Blvd, Suite 200
Los Angeles, CA 90025
The Greater Southern California Node joined the CTN in 2019. The overall objective of the GSCN is to advance the mission of the National Institute on Drug Abuse (NIDA) by participating in and supporting research focused on treatment interventions for substance use disorders (SUDs), including opioid use disorder (OUD) and the opioid crisis addressed by the “HEAL” initiative (Helping End Addiction Long Term) of the National Institutes of Health. Toward that goal, the GSCN collaborates with other nodes of the NIDA Clinical Trials Network (CTN) to design and conduct research efforts that explore innovative methods to increase utilization of evidence-based treatments for SUDs, with a special emphasis on medication treatment for OUD. An initial focus of the GSCN is to implement research aimed at expansion and improvement of medication treatment for OUD across diverse regions with under-served, high-need populations in rural settings where SUD services are lacking.
Grantee Institution: Integrated Substance Abuse Programs, University of California, Los Angeles